Comparative Study of Metformin Versus Doxycycline in Moderate to Severe Adult Acne Vulgaris Patients.
NCT ID: NCT06252194
Last Updated: 2024-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE2
120 participants
INTERVENTIONAL
2023-03-05
2024-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients will be asked to take doxycycline along with tropical treatment in one group and metformin along with tropical treatment in another group.
Researcher will compare the clinical improvement in two groups.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Topical Metformin Versus Topical Ketotifen in Melasma Treatment
NCT06942390
Study Comparing Test to Aczone 5% and Both to a Placebo Control in the Treatment of Acne Vulgaris
NCT02929719
Treatment of Moderate to Severe Facial Acne Vulgaris
NCT00612573
A Efficacy and Safety of Duac™Compared With Clindamycin Phosphate Gel in the Treatment of Mild to Moderate Acne Vulgaris
NCT01915732
Metformin for the Treatment of Hidradenitis Suppurativa (HS)
NCT04649502
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
Metformin 500 mg twice daily along with topical retinoids for 12 weeks
Metformin and doxycycline
Metformin 500 mg tablet twice daily
Group B
Doxycycline 100 mg twice daily along with topical retinoids for 12 weeks
Metformin and doxycycline
Metformin 500 mg tablet twice daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Metformin and doxycycline
Metformin 500 mg tablet twice daily
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
\-
Exclusion Criteria
* Pregnancy and lactation
* History of corticosteroids intake
* Suffering from malignancy or any cosmetic induced acne
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Muhammad Marnush
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
BSMMU
Dhaka, , Bangladesh
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BSMMU/2022/11379
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.